Insider · CIK 0001202335

GRYSKA DAVID W

Reports to the SEC for 13 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001202335

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CELCCelcuity Inc.A Award	Director	AAward	+893 sh	—	—	893
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)]D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,940 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−18.4K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2026-06-11	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.2K sh	—	—	19,188
2026-06-11	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+4,666 sh	—	—	19,900
2026-05-29	FBRXForte Biosciences, Inc. · Restricted Stock UnitsA Award	Director	AAward	+18.4K sh	—	—	18,353
2025-06-12	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75.2K sh	—	—	75,187
2025-03-20	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2024-12-05	DFTXDefinium Therapeutics, Inc.P Purchase	Director	PPurchase	+2,500 sh	$7.17	+$17.9K	19,851
2024-08-23	DFTXDefinium Therapeutics, Inc.P Purchase	Director	PPurchase	+3,500 sh	$5.98	+$20.9K	17,351
2024-08-20	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-06-10	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,506
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,260 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,750 sh	—	—	0
2023-12-14	Seagen Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−49K sh	$229.00	−$11.2M	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,260 sh	—	—	0
2023-12-14	Seagen Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,044 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,676 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,462 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,038 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,260 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,171 sh	—	—	0
2023-12-14	Seagen Inc.Stock Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,260 sh	—	—	0
2023-09-19	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-07-31	FBRXForte Biosciences, Inc.A Award	Director	AAward	+149K sh	$1.01	+$150K	148,514
2023-06-21	DFTXDefinium Therapeutics, Inc.A Award	Director	AAward	+13.9K sh	—	—	13,851
2023-06-21	DFTXDefinium Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.6K sh	—	—	37,594
2023-06-21	DFTXDefinium Therapeutics, Inc. · Director's Deferred Share UnitsA Award	Director	AAward	+13.1K sh	—	—	13,131
2023-05-31	Seagen Inc.A Award	Director	AAward	+2,044 sh	—	—	51,047
2023-02-13	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,750 sh	—	—	0
2023-02-13	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,750 sh	$36.70	+$321K	49,003
2023-01-10	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-11-21	AERIE PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	$15.25	−$175K	0
2022-11-21	AERIE PHARMACEUTICALS INCD Disposition to Issuer	Director	DDisposition to Issuer	−1,996 sh	$15.25	−$30.4K	0
2022-11-21	AERIE PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,800 sh	$1.98	−$15.4K	0
2022-11-21	AERIE PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.9K sh	$9.14	−$154K	0
2022-11-11	Seagen Inc.S Sale	Director	SSale	−7,500 sh	$129.10	−$968K	40,253
2022-06-09	AERIE PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+16.9K sh	—	—	16,854
2022-06-09	AERIE PHARMACEUTICALS INCA Award	Director	AAward	+6,245 sh	—	—	11,495
2022-05-13	Seagen Inc.A Award	Director	AAward	+1,503 sh	—	—	47,753
2022-05-13	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+3,676 sh	—	—	3,676
2022-04-19	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−690 sh	—	—	0
2022-04-19	Seagen Inc.S Sale	Director	SSale	−690 sh	$145.08	−$100K	46,250
2022-04-19	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,794 sh	—	—	2,206
2022-04-19	Seagen Inc.S Sale	Director	SSale	−1,794 sh	$143.32	−$257K	46,250
2022-04-19	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,516 sh	—	—	690

Recent filings

Accepted (ET)
Oct 5 17:084
GRYSKA DAVID W0001202335-26-000007
SEC(opens sec.gov)
Aug 274
GRYSKA DAVID W0001202335-26-000003
SEC(opens sec.gov)
Jun 154
GRYSKA DAVID W0001193125-26-271163
SEC(opens sec.gov)
Jun 24
GRYSKA DAVID W0001202335-26-000002
SEC(opens sec.gov)
Jun 164
GRYSKA DAVID W0000950170-25-086763
SEC(opens sec.gov)
Mar 214
GRYSKA DAVID W0001415889-25-008785
SEC(opens sec.gov)
Dec 54
GRYSKA DAVID W0000950170-24-133724
SEC(opens sec.gov)
Aug 264
GRYSKA DAVID W0000950170-24-100668
SEC(opens sec.gov)
Aug 224
GRYSKA DAVID W0001415889-24-022009
SEC(opens sec.gov)
Jun 124
GRYSKA DAVID W0000950170-24-072468
SEC(opens sec.gov)
Dec 154
GRYSKA DAVID W0000950170-23-070865
SEC(opens sec.gov)

Companies

Address

2800 CAMPUS DRIVE SUITE 140

MINNEAPOLIS, MN, 55441